Galenisys Newsletter : May 2026 Table of Contents * TALES FROM FARAWAY PHARMA Catastrophic Issues!! by Steve Biddulph * LUCY IN THE SKY WITH DONALD Too many crazies in “high” places already! By Tony Dunford * NO HIDING PLACE Whether it’s an Internal Audit, or a PAI, Galenisys know where to look by
Galenisys Newsletter : April 2026 Table of Contents * GALENISYS NEWS An update on some of the interesting assignments coming our way * TALES FROM FARAWAY PHARMA An update on some of the interesting assignments coming our way * UNDER THE INFLUENCE Chinese tea in a special suite by Steve Biddulph * THEN AND NOW
Galenisys Newsletter : March 2026 Table of Contents * TALES FROM FARAWAY PHARMA It seemed perfect, until it wasn’t …… by Steve Biddulph * IT MUST HAVE BEEN THE SUGAR, …., YEAH, ……… (I THINK). The 25mcg strength puzzle By Bill Torpey * DODGY DOCUMENTS IN THE LAND OF PAPER DRAGONS But where is the factory?
Galenisys Newsletter : February 2026 Table of Contents * TALES FROM FARAWAY PHARMA by Steve Biddulph * LETS BE CLEAR SEEING THROUGH THE FOG by The Editor * "GENERATION Z", AND FUTURE HEALTH by Hannah Westwood * THE WAR GOES ON by The Editor * DOWNSIZING WITH ELI LILLY AND NOVO NORDISK by The
Galenisys Newsletter : January 2026 Table of Contents * TALES FROM FARAWAY PHARMA India & an Unqualified Success By Steve Biddulph * SUCCESSFUL PARTNERING WITH ASIAN COMPANIES Plenty of due diligence necessary By Richard van Duyse * PHARMA FASHION Where will the GLP 1s take us By The Editor * THE FAMILY ENVIRONMENT Christmas in
Galenisys Newsletter : December 2025 Table of Contents * TALES FROM FARAWAY PHARMA By Steve Biddulph * WHAT PANDEMIC ? By The Editor * VALIDATION, WHOSE BABY IS IT! By Bill Torpey * WHICH STANDARDS DO YOU HAVE? By The Editor * EASY COME – EASY GO By The Editor TALES FROM FARAWAY PHARMA by Steve Biddulph Fellow
Galenisys Newsletter : November 2025 Table of Contents By Tony Dunford Editor * TALES FROM FARAWAY PHARMA COLUMBIA: THE SEEN & UNSEEN RISKS By Steve Biddulph * SHRIMPS, ALIENS, AND HEALTH SECRETARIES By The Editor * CHECK THAT FAT! Small problems can cause big delays By Bill Torpey * TYLENOL AND SMARTIES The President’s
Galenisys Newsletter : October 2025 Table of Contents By Tony Dunford Editor * CLOSE SHAVES & COMPANY EXISTENCE By Bill Torpey * Wrong again, Mr Secretary! Robert F Kennedy Junior creates another headache. By The Editor * TALES FROM FARAWAY PHARMA My rumble in the jungle By Steve Biddulph * THE RETURN OF THE VIRUS.
Galenisys Newsletter : September 2025 Table of Contents By Tony Dunford Editor * WELCOME BACK, WE ARE READY TO GET STUCK IN! Steve Biddulph * TALES FROM FARAWAY PHARMA Weird situations crop up even in our industry. By AUBONNE * WATER IS SO IMPORTANT IN THE PHARMA INDUSTRY Like freedom – eternal vigilance is required
Galenisys Newsletter : August 2025 Table of Contents By Tony Dunford Editor * TALES FROM FARAWAY PHARMA “Dangerous Questions” By Steve Biddulph * THE PHARMA TARIFF TIDE The Editor * THE VALUABLE PROCESS OF FREEZE DRYING By Richard van Duyse * VACCINES, GOOD & BAD NEWS By The Editor TALES FROM FARAWAY PHARMA By Steve
Galenisys Newsletter : July 2025 Table of Contents By Tony Dunford Editor * TALES FROM FARAWAY PHARMA Part 1 Dress Code Ecuador. By Steve Biddulph * COMBATING FAKE MEDICINE By Richard van Duyse * OUT OF TOUCH, OUT OF POCKET! “If you want to influence events, be there” By The Editor * A GOOD READ
Galenisys Newsletter : June 2025 Table of Contents By Tony Dunford Editor * The President vs. Big Pharma (as of mid-May!) By the Editor * FACING DISASTER: Knowledge and Experience Count By Bill Torpey * Due Diligence versus Audit/Inspection By Richard van Duyse * Flying blind? Less tracking and forecasting. The Editor The President